ASCO: Gastric Cancer Patients Respond to Trastuzumab Deruxtecan
Overall survival also extended with conjugate treatment In a small, phase II trial, patients with...
Read MoreJun 2, 2020
Overall survival also extended with conjugate treatment In a small, phase II trial, patients with...
Read MoreJun 1, 2020
MONDAY, June 1, 2020 (HealthDay News) — For patients with cancer and COVID-19, mortality is...
Read MoreMay 30, 2020
FRIDAY, May 29, 2020 (HealthDay News) — For men with advanced prostate cancer, the oral...
Read MoreMay 27, 2020
New research was presented at AATS 2020, the virtual Annual Meeting of the American Association...
Read MoreMay 25, 2020
An FDA Covid-19 Town Hall, ASCO’s virtual meeting, upcoming drug approvals, and more Here is...
Read MoreMay 20, 2020
Three days packed with presentations The American Society of Clinical Oncology is the leading...
Read MoreMay 19, 2020
New research was presented at SCAI 2020, the virtual Society for Cardiovascular Angiography &...
Read MoreMay 1, 2020
Although research has linked pre-existing intratumoral immune response—characterized by presence...
Read MoreMay 1, 2020
Evidence suggests that, despite increased public health efforts to discourage teens from using...
Read MoreMay 1, 2020
Despite research suggesting that mutation in ESR1 is an acquired mechanism of resistance to...
Read MoreMay 1, 2020
Although previous studies suggest objective responses with BRAF and MEK inhibitors in the majority...
Read MoreMay 1, 2020
With prior research indicating that patients with cancer are generally more vulnerable to...
Read MoreApr 6, 2020
Based on the hypothesis that HIV-infected individuals have higher rates of mortality following...
Read MoreApr 6, 2020
Empirical evidence supporting the cost savings associated with direct-acting antivirals (DAAs) in...
Read MoreApr 6, 2020
Although evidence indicates that HIV-related stigma appears to be a barrier to engagement in care,...
Read MoreApr 6, 2020
Although the linkage-to-care intervention Rapid Start—designed to start patients newly diagnosed...
Read MoreApr 6, 2020
Evidence suggests that tools for identifying populations who may benefit from PrEP are required...
Read MoreApr 2, 2020
Subgroup analysis shows time spent in target glucose range increased in auto mode versus manual mode
Read MoreApr 1, 2020
Mean change in HbA1c not significantly different with regular human insulin, rapid-acting insulin
Read MoreApr 1, 2020
Reduction in BMI standard-deviation score greater for liraglutide + lifestyle therapy versus placebo
Read More